Delhi Man Takes HIV Preventive Drugs on AI advice, Condition Critical

Written By :  Anshika Mishra
Published On 2026-02-02 12:17 GMT   |   Update On 2026-02-02 12:17 GMT
Advertisement

A Delhi-based man is reportedly in a critical condition after consuming HIV preventive medication based on guidance received from an artificial intelligence (AI) platform, renewing concerns over self-medication and the growing reliance on digital tools for medical advice.

As per available information, the individual allegedly began taking HIV post-exposure prophylaxis (PEP) drugs without consulting a qualified healthcare professional. Shortly after initiating the medication, he developed serious health complications and had to be admitted to a hospital, where doctors described his condition as critical. The adverse reaction is suspected to be linked to the unsupervised use of the drugs.

For more details, check out the full story on the link below:

AI Advice Leads Delhi Man to Self-Medicate HIV Drugs, Condition Critical

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News